Wedbush Securities Reacts To Regulus Therapeutics Inc Announcing ATHENA Natural History Study
September 19, 2014 at 07:52 AM EDT
In a report published Friday, Wedbush Securities analyst Liana Moussatos reiterated an Outperform rating and $19.00 price target on ...